What is the projected market valuation of the US energy transition market by 2035?

The projected market valuation is expected to reach 768.03 USD Million by 2035. Read More

What was the overall market valuation of the US energy transition market in 2024?

The overall market valuation was 297.58 USD Million in 2024. Read More

What is the expected CAGR for the US energy transition market during the forecast period 2025 - 2035?

The expected CAGR for the market during this period is 9.0%. Read More

Which companies are considered key players in the US energy transition market?

Key players include NextEra Energy, Iberdrola, Enel, Orsted, Siemens Gamesa, Vestas Wind Systems, Brookfield Renewable Partners, TotalEnergies, and Shell. Read More

What are the main segments of the US energy transition market?

The main segments include Energy Source, Technology, Application, and End Use. Read More

What was the valuation of the Renewable Energy segment in 2024?

The Renewable Energy segment was valued at 120.0 USD Million in 2024. Read More

How much is the Wind Power segment projected to be worth by 2035?

The Wind Power segment is projected to reach 200.0 USD Million by 2035. Read More

What is the expected valuation for the Industrial End Use segment by 2035?

The Industrial End Use segment is expected to be valued at 388.03 USD Million by 2035. Read More

What was the valuation of Smart Grid Technologies in 2024?

Smart Grid Technologies had a valuation of 107.58 USD Million in 2024. Read More

How does the valuation of Fossil Fuels compare to that of Nuclear Energy in 2024?

In 2024, Fossil Fuels were valued at 97.58 USD Million, whereas Nuclear Energy was valued at 80.0 USD Million. Read More

US Energy Transition Market

ID: MRFR/EnP/16553-HCR

100 Pages

Garvit Vyas

Last Updated: April 06, 2026

US Energy Transition Market Research Report By End Use (Residential, Commercial, Industrial), By Technology (Solar Power, Wind Power, Hydropower, Energy Storage, Smart Grid Technologies), By Application (Power Generation, Transportation, Industrial Processes, Heating and Cooling), By Energy Source (Renewable Energy, Nuclear Energy, Fossil Fuels) - Forecast to 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Energy Source (USD Million)
  1. 4.1.1 Renewable Energy
  2. 4.1.2 Nuclear Energy
  3. 4.1.3 Fossil Fuels
2. 4.2 Pharmaceutical, BY Technology (USD Million)
  1. 4.2.1 Solar Power
  2. 4.2.2 Wind Power
  3. 4.2.3 Hydropower
  4. 4.2.4 Energy Storage
  5. 4.2.5 Smart Grid Technologies
3. 4.3 Pharmaceutical, BY Application (USD Million)
  1. 4.3.1 Power Generation
  2. 4.3.2 Transportation
  3. 4.3.3 Industrial Processes
  4. 4.3.4 Heating and Cooling
4. 4.4 Pharmaceutical, BY End Use (USD Million)
  1. 4.4.1 Residential
  2. 4.4.2 Commercial
  3. 4.4.3 Industrial
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 NextEra Energy (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Iberdrola (ES)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Enel (IT)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Orsted (DK)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Siemens Gamesa (ES)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Vestas Wind Systems (DK)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Brookfield Renewable Partners (CA)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 TotalEnergies (FR)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Shell (GB)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY ENERGY SOURCE
3. 6.3 US MARKET ANALYSIS BY TECHNOLOGY
4. 6.4 US MARKET ANALYSIS BY APPLICATION
5. 6.5 US MARKET ANALYSIS BY END USE
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY ENERGY SOURCE, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY ENERGY SOURCE, 2024 TO 2035 (USD Million)
14. 6.14 PHARMACEUTICAL, BY TECHNOLOGY, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
16. 6.16 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
18. 6.18 PHARMACEUTICAL, BY END USE, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY END USE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY ENERGY SOURCE, 2025-2035 (USD Million)
  2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
  4. 7.2.4 BY END USE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Pharmaceutical Market Segmentation

Pharmaceutical By Energy Source (USD Million, 2025-2035)

Renewable Energy
Nuclear Energy
Fossil Fuels

Pharmaceutical By Technology (USD Million, 2025-2035)

Solar Power
Wind Power
Hydropower
Energy Storage
Smart Grid Technologies

Pharmaceutical By Application (USD Million, 2025-2035)

Power Generation
Transportation
Industrial Processes
Heating and Cooling

Pharmaceutical By End Use (USD Million, 2025-2035)

Residential
Commercial
Industrial

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”